Arizona State Retirement System grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 12.4% during the ...

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

Oppenheimer Asset Management Inc. trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 28.0% in the 4th quarter, according to the company in its most recent ...

"This highlights a distinct mechanism of cytotoxicity, where excessive resection, rather than failed DNA repair by homologous recombination, underpins the vulnerability of BRCA-deficient cells to nick ...

This article discusses the mechanisms of bacterial transduction and how scientists can utilize it to manipulate bacterial ...

Colossal Biosciences has altered several genes in mice to make them look more mammoth-like, but the company is far from its ...

Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors. LAE120 ...

Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...

Mayo Clinic's Precision Mouse Engineering Core in Minnesota makes embryonic stem (ES) cell-based gene-targeted mice available to researchers.